/cdn.vox-cdn.com/uploads/chorus_image/image/10092105/20120505_jla_aa9_632.0.jpg)
Uh oh.
Ultimate Fighting Championship (UFC) heavyweight super-slugger Lavar Johnson is in "Big" trouble with the California State Athletic Commission (CSAC).
The Strikeforce import is coming off a unanimous decision loss to Brendan Schaub at the UFC 157 pay-per-view (PPV) event last month in Anaheim (full results here), but has more to worry about than just wins and losses, according to a report from MMA Junkie.
Johnson has been flagged for elevated levels of testosterone. An additional carbon isotope ratio test "confirmed the testosterone was consistent with the administration of a steroid," according to CSAC Executive Officer Andy Foster [who] clarified that the initial failure was not due to an elevated testosterone-to-epitestosterone (T/E) level, but could not provide further details on Johnson's failure at the time of this writing.
His loss to "The Hybrid" marked Johnson's second straight inside the Octagon, leaving him at 2-2 since his 2012 debut. "Big" was expected to remain employed, despite the recent roster cuts, but this run-in with the CSAC could ultimately change that decision.
Especially considering UFC President Dana White's new no-nonsense stance on testosterone.
No disciplinary action has been taken at this time and all other athletes tested for drugs of abuse and performance enhancing substances following UFC 157 passed with flying colors. As always, we'll keep you abreast of all the latest developments to this story as they become available.